Hualan Biological Vaccine Inc. (SHE:301207)
China flag China · Delayed Price · Currency is CNY
14.05
-0.15 (-1.06%)
Nov 17, 2026, 3:04 PM CST

Hualan Biological Vaccine Revenue

Hualan Biological Vaccine had revenue of 256.50M CNY in the quarter ending September 30, 2026, a decrease of -65.62%. This brings the company's total for the last twelve months to 697.41M, down -28.58% year-over-year. In the year 2025, Hualan Biological Vaccine had annual revenue of 1.20B with 6.62% growth. That makes Hualan Biological Vaccine the 22,366th largest company in the world by revenue and 4,082nd in China.

Revenue (ttm)
697.41M
Revenue Growth
-28.58%
P/S Ratio
11.99
Revenue / Employee
985.04K
Employees
708
Market Cap
8.36B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Flu vaccine 1.20B 99.7%
  • Others 3.26M 0.3%

By Geography

Chart
  • China 1.20B 99.9%
  • Foreign 1.58M 0.1%

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.20B74.69M6.62%
Dec 31, 20241.13B-1.28B-53.21%
Dec 31, 20232.41B584.79M32.03%
Jan 1, 20231.83B-4.17M-0.23%
Jan 1, 20221.83B-596.52M-24.59%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.